Andrew Witty, the CEO of UnitedHealth Group, was unexpectedly replaced on Tuesday. His resignation reportedly stemmed from “personal reasons,” though many have speculated about the broader implications.
Witty had recently testified before the Senate Finance Committee regarding significant data breaches at Change Healthcare, which is owned by UnitedHealth. Following his resignation, Stephen J. Hemsley, the former CEO and current chairman, stepped in as interim CEO. However, a representative for the company declined to provide additional comments on the situation.
Following the leadership change, UnitedHealth’s stock plummeted by more than 16%. The company, which is one of the largest healthcare organizations globally, has also faced various public challenges lately. It owns Change Healthcare, a payment processing firm critical to hospitals and healthcare providers. Last year, a major cyber attack disrupted services for many, affecting around 100 million individuals.
In another incident shaking the industry, Brian Thompson, a prominent figure and former CEO of UnitedHealthcare, was tragically shot in Manhattan in December. This incident spurred significant consumer backlash against high healthcare costs and frequent denied claims. The accused, Luigi Mangione, has pleaded not guilty to several federal charges, with some viewing him as a sort of vigilante due to public outrage over healthcare practices. Fundraising for his legal defense has reportedly exceeded $1 million.
During his tenure, Witty attempted to address rising discontent within the healthcare industry, stating, “We understand and share the desire to create a system that works well for everyone.” However, it seems that worsening economic conditions within UnitedHealth ultimately led to his departure.
The company has been grappling with increasing costs within its Medicare Advantage segment, traditionally seen as profitable. Now, many healthcare CEOs, including those at competitors like CVS Health, have found themselves confronted with similar challenges, resulting in recent leadership changes.
In a statement, UnitedHealth announced that with ongoing care activities accelerating, it was withholding its outlook for 2025 while acknowledging “higher than expected” costs in its Medicare Advantage operations. This suggests that their actions in the market may need a reevaluation, particularly given the unexpected frequency of doctor visits among their senior Medicare clientele, which has risen costs significantly.
